Stanford Autonomic Disorders Program in the News
Mitchell Miglis, MD discusses a recent landmark review on identifying biomarkers in isolated REM sleep behavior disorder that predict the development of diseases such as Parkinson's, DLB, & MSA.
Some COVID-19 patients have developed post-infectious neurological symptoms suggestive of dysautonomia. Persistent dizziness, lightheadedness, or tachycardia upon standing, that manifests months after COVID-19 infection, could indicate a diagnosis of postural orthostatic tachycardia syndrome (POTS). Dr. Mitchell Miglis speaks about the association of COVID-19 and dysautonomia and his efforts to spearhead a Stanford research study looking at autonomic dysfunction in post-COVID syndrome.
Some COVID-19 patients aren't getting better. Major medical centers are trying to figure out how to help
NBC News consults Dr. Mitchell Miglis on lingering symptoms in patients months after COVID-19 infection. Dr. Miglis shares his thoughts on the medical community's rising suspicion of the virus's damage to the autonomic nervous system.
Usually when we dream our minds are vibrant and active while our bodies remain motionless. REM sleep behavior disorder is a sleep condition where the paralysis that normally takes hold of our bodies during REM sleep malfunctions. What results is a frightening condition characterized by active and sometimes violent dream enactment. Dr. Mitchell Miglis discusses the underlying pathophysiology of the disorder, its potential as a marker for Parkinson's disease, and his research in the field.
What do Beyoncé and autonomic disorders have in common? More than you might think. American singer, songwriter and sister to Beyoncé, Solange Knowles revealed she’s been diagnosed with an autonomic disorder. Self Magazine asks director of Stanford’s autonomic disorders program and professor of neurology & neurological sciences, Safwan Jaradeh, MD, to give us a breakdown of exactly what that could mean.